Portal:COVID-19/FeaturedPathways
From WikiPathways
Line 59: | Line 59: | ||
* [[Pathway:WP4927]] | * [[Pathway:WP4927]] | ||
- | * [[Pathway: | + | * [[Pathway:WP4876]] |
- | * [[Pathway: | + | * [[Pathway:WP4883]] |
- | * [[Pathway: | + | * [[Pathway:WP4891]] |
- | * [[Pathway: | + | * [[Pathway:WP4884]] |
- | * [[Pathway: | + | |
- | * [[Pathway: | + | * [[Pathway:WP4904]] |
+ | * [[Pathway:WP4936]] | ||
+ | |||
* [[Pathway:WP2513]] | * [[Pathway:WP2513]] | ||
* [[Pathway:WP2509]] | * [[Pathway:WP2509]] |
Revision as of 19:56, 9 September 2020
SARS-CoV-2 Pathways
Image does not exist Collaborative project for curation of biological processes involved in the COVID-19 disease after SARS-Cov-2 infection. |
Image does not exist SARS-CoV-2 includes a novel Orf10 that interacts with multiple members of the Cullin 2 ubiquitin ligase complex. |
Image does not exist The induction and signaling of type I interferon with specific SARS-CoV-2 protein and relevant drug. |
Image does not exist |
Image does not exist Orf3a from SARS-CoV has been shown to bind TRAF3 and activate the NLRP3 inflammasome. |
Image does not exist |
Image does not exist Experimental pathway to investigate overlap of virus-host interaction and adverse outcome pathways |
Image does not exist Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis |
Image does not exist |
Image does not exist |
Other coronaviruses: MERS, SARS-CoV, etc
Image does not exist Lipid metabolism alternations that are related to infection by the corona virus. |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
More about ACE2
Image does not exist |
Image does not exist |
List of featured pathways: